Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Bladder efficacy demonstrated for KATP channel opener

Dec. 19, 1997

Fujisawa describes preparation of new 5alpha-reductase inhibitor for BPH

Dec. 15, 1997

Sankyo isolates natural products for BPH

Nov. 28, 1997

First launch for Detrusitol

Nov. 21, 1997

Development of tolerance to OPC-31260 effects in rats after chronic treatment

Nov. 17, 1997

OP-1 exhibits protective effects against kidney damage

Nov. 12, 1997

PNU-96293: KATP channel blocker and eukalemic diuretic

Nov. 11, 1997

SB-234551 prevents radiocontrast-induced renal vasoconstriction in dogs

Nov. 10, 1997

RenaGel with and without calcium effective in ESRD

Nov. 10, 1997

New technology for BPH enters clinical trials in U.S.

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...